Diamyd Medical to present at Precision Medicine conference
CEO Ulf Hannelius has been invited to give a talk at the “Precision medicine – From patient to lab and back again” conference organized by the Copenhagen Bioscience Cluster, a Novo Nordisk foundation initiative.The talk, which is based on an abstract submitted to the conference entitled “Developing data-driven precision therapies for Type 1 diabetes”, will focus on how the data collected in Diamyd Medical’s clinical trials together with scientific advances in the field have informed the development of the precision medicine diabetes vaccine Diamyd[®] for the treatment of type 1 diabetes.